Management ChangeJun 15, 2026, 08:31 AM
Conexeu Sciences Appoints 3 New Directors, Names CCO & Advisor
AI Summary
Conexeu Sciences Inc. announced significant additions to its leadership team, effective immediately. Ana Bastiani-Posner, April Burke, and Andrew Costa were appointed to the Board of Directors, bringing expertise in healthcare, finance, and strategic growth. Co-Founder David Bogart was named Chief Commercial Officer to lead commercialization efforts. Additionally, Melinda Farina joined the advisory board, adding deep experience in medical aesthetics. These appointments aim to support the company's growth phase and commercialization strategy for its CXU™ platform.
Key Highlights
- Ana Bastiani-Posner appointed to Board of Directors, Chair of Compensation Committee, and member of Audit Committee.
- April Burke appointed to Board of Directors, member of Audit Committee and Compensation Committee.
- Andrew Costa appointed to Board of Directors, Chair of Audit Committee, and member of Nominating and Corporate Governance Committee.
- Co-Founder David Bogart appointed Chief Commercial Officer to lead commercialization efforts.
- Melinda Farina, founder of Integrated Aesthetics Consulting, joins the advisory board.
- New appointments add significant experience across healthcare, finance, capital markets, and operations.
- The company is advancing its CXU™ platform and long-term commercialization strategy.
Price Impact
More from CNXU